Emergent BioSolutions Inc
Emergent BioSolutions Inc/ US29089Q1058 /
EBS
|
24/05/2024 21:59:52
|
Chg.
-
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
4.75USD
|
-
|
14,519
Turnover: 68,949.82 |
-Bid Size: - |
-Ask Size: - |
247.34 mill.USD |
- |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
-14.85 USD |
251.90% |
| EPS Diluted: |
-14.85 USD |
251.90% |
| Revenues per Share: |
20.10 USD |
-9.81% |
| Book Value per Share: |
12.44 USD |
-55.06% |
| Cash Flow per Share: |
-3.95 USD |
481.07% |
| Dividend per Share: |
- USD |
- |
| Total |
in mill. |
|
| Revenues: |
1,049.30 USD |
-6.10% |
| Net Income: |
-760.50 USD |
259.40% |
| Operating Cash Flow: |
-206.30 USD |
- |
| Cash and Cash Equivalents: |
111.70 USD |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
- |
- |
| P/S Ratio: |
0.23 |
0.12 |
| P/BV ratio: |
0.38 |
0.19 |
| P/CF Ratio: |
-1.19 |
-0.61 |
| PEG: |
0.00 |
- |
| Earnings Yield: |
-314.62% |
-618.75% |
| Dividend Yield: |
- |
- |
| Market Capitalization |
|
| Market Capitalization: |
247.34 mill. USD |
125.29 mill. USD |
| Free Float Market Cap.: |
- USD |
- USD |
| Market Cap. / Employee: |
- USD |
- USD |
| Shares Outstanding: |
52.4 mill. |
|
Profitability
| Gross Profit Margin: |
32.77% |
| EBIT Margin: |
-69.23% |
| Net Profit Margin: |
-72.48% |
| Return on Equity: |
-117.13% |
| Return on Assets: |
-41.71% |
Financial Strength
| Liquidity I / Cash Ratio: |
17.15% |
| Liquidity II / Quick Ratio: |
46.48% |
| Liquidity III / Current Ratio: |
104.33% |
| Debt / Equity Ratio: |
180.79% |
| Dynam. Debt / Equity Ratio: |
-569.03% |
Efficiency
| Employees: |
- |
| Personal Expenses / Employee: |
- USD |
| Revenues / Employee: |
- USD |
| Net Income / Employee: |
- USD |
| Total Assets / Employee: |
- USD |
| * Fiscal Year End: |
31/12/2023 |
| Accounting Standard: |
US GAAP |
